MENU
+Compare
CVKD
Stock ticker: NASDAQ
AS OF
Jan 30, 04:59 PM (EDT)
Price
$19.03
Change
+$0.49 (+2.64%)
Capitalization
33.05M

CVKD Cadrenal Therapeutics Inc Forecast, Technical & Fundamental Analysis

Industry Biotechnology
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CVKD with price predictions
Jan 29, 2025

Aroon Indicator for CVKD shows an upward move is likely

CVKD's Aroon Indicator triggered a bullish signal on January 29, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 80 similar instances where the Aroon Indicator showed a similar pattern. In of the 80 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 15, 2025. You may want to consider a long position or call options on CVKD as a result. In of 34 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CVKD moved above its 50-day moving average on January 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CVKD crossed bullishly above the 50-day moving average on January 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CVKD advanced for three days, in of 104 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CVKD moved out of overbought territory on January 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator moved out of overbought territory. In of the 8 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 20 cases where CVKD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVKD broke above its upper Bollinger Band on January 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVKD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.940) is normal, around the industry mean (15.749). P/E Ratio (0.000) is within average values for comparable stocks, (88.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.848). CVKD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (276.027).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVKD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CVKD is expected to report earnings to fall 93.12% to -15 cents per share on March 17

Cadrenal Therapeutics Inc CVKD Stock Earnings Reports
Q4'24
Est.
$-0.15
Q3'24
Missed
by $2.06
Q2'24
Missed
by $2.13
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.02
The last earnings report on November 07 showed earnings per share of -218 cents, missing the estimate of -11 cents. With 31.37K shares outstanding, the current market capitalization sits at 33.05M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QUAD7.020.26
+3.85%
QUAD/GRAPHICS
YUM130.731.56
+1.21%
Yum! Brands
WTM1955.0020.73
+1.07%
White Mountains Insurance Group Ltd
KIRK1.560.01
+0.65%
Kirkland's
GENI8.940.04
+0.45%
Genius Sports Limited

CVKD and Stocks

Correlation & Price change

A.I.dvisor tells us that CVKD and GDTC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-2.32%
GDTC - CVKD
29%
Poorly correlated
+2.81%
REVB - CVKD
26%
Poorly correlated
-12.26%
GOSS - CVKD
22%
Poorly correlated
-0.24%
MRKR - CVKD
22%
Poorly correlated
-7.89%
VINC - CVKD
22%
Poorly correlated
-5.45%
More